Controlled drug delivery systems for oral cancer treatment--current status and future perspectives
Oral squamous cell carcinoma (OSCC), which encompasses the oral cavity-derived malignancies, is a devastating disease causing substantial morbidity and mortality in both men and women. It is the most common subtype of the head and neck squamous cell carcinoma (HNSCC), which is ranked the sixth most...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
Multidisciplinary Digital Publishing Institute
2020
|
| Online Access: | https://hdl.handle.net/1721.1/125310 |
| _version_ | 1826195039734202368 |
|---|---|
| author | Koutsopoulos, Sotirios |
| author2 | Massachusetts Institute of Technology. Center for Biomedical Engineering |
| author_facet | Massachusetts Institute of Technology. Center for Biomedical Engineering Koutsopoulos, Sotirios |
| author_sort | Koutsopoulos, Sotirios |
| collection | MIT |
| description | Oral squamous cell carcinoma (OSCC), which encompasses the oral cavity-derived malignancies, is a devastating disease causing substantial morbidity and mortality in both men and women. It is the most common subtype of the head and neck squamous cell carcinoma (HNSCC), which is ranked the sixth most common malignancy worldwide. Despite promising advancements in the conventional therapeutic approaches currently available for patients with oral cancer, many drawbacks are still to be addressed; surgical resection leads to permanent disfigurement, altered sense of self and debilitating physiological consequences, while chemo- and radio-therapies result in significant toxicities, all affecting patient wellbeing and quality of life. Thus, the development of novel therapeutic approaches or modifications of current strategies is paramount to improve individual health outcomes and survival, while early tumour detection remains a priority and significant challenge. In recent years, drug delivery systems and chronotherapy have been developed as alternative methods aiming to enhance the benefits of the current anticancer therapies, while minimizing their undesirable toxic effects on the healthy non-cancerous cells. Targeted drug delivery systems have the potential to increase drug bioavailability and bio-distribution at the site of the primary tumour. This review confers current knowledge on the diverse drug delivery methods, potential carriers (e.g., polymeric, inorganic, and combinational nanoparticles; nanolipids; hydrogels; exosomes) and anticancer targeted approaches for oral squamous cell carcinoma treatment, with an emphasis on their clinical relevance in the era of precision medicine, circadian chronobiology and patient-centred health care. ©2019 Keywords: oral, head and neck squamous cell carcinoma; targeted therapies; drug delivery systems; nanoparticles; controlled drug delivery; circadian clock; chronotherapy; precision medicine |
| first_indexed | 2024-09-23T10:05:49Z |
| format | Article |
| id | mit-1721.1/125310 |
| institution | Massachusetts Institute of Technology |
| last_indexed | 2024-09-23T10:05:49Z |
| publishDate | 2020 |
| publisher | Multidisciplinary Digital Publishing Institute |
| record_format | dspace |
| spelling | mit-1721.1/1253102022-09-26T15:42:06Z Controlled drug delivery systems for oral cancer treatment--current status and future perspectives Koutsopoulos, Sotirios Massachusetts Institute of Technology. Center for Biomedical Engineering Oral squamous cell carcinoma (OSCC), which encompasses the oral cavity-derived malignancies, is a devastating disease causing substantial morbidity and mortality in both men and women. It is the most common subtype of the head and neck squamous cell carcinoma (HNSCC), which is ranked the sixth most common malignancy worldwide. Despite promising advancements in the conventional therapeutic approaches currently available for patients with oral cancer, many drawbacks are still to be addressed; surgical resection leads to permanent disfigurement, altered sense of self and debilitating physiological consequences, while chemo- and radio-therapies result in significant toxicities, all affecting patient wellbeing and quality of life. Thus, the development of novel therapeutic approaches or modifications of current strategies is paramount to improve individual health outcomes and survival, while early tumour detection remains a priority and significant challenge. In recent years, drug delivery systems and chronotherapy have been developed as alternative methods aiming to enhance the benefits of the current anticancer therapies, while minimizing their undesirable toxic effects on the healthy non-cancerous cells. Targeted drug delivery systems have the potential to increase drug bioavailability and bio-distribution at the site of the primary tumour. This review confers current knowledge on the diverse drug delivery methods, potential carriers (e.g., polymeric, inorganic, and combinational nanoparticles; nanolipids; hydrogels; exosomes) and anticancer targeted approaches for oral squamous cell carcinoma treatment, with an emphasis on their clinical relevance in the era of precision medicine, circadian chronobiology and patient-centred health care. ©2019 Keywords: oral, head and neck squamous cell carcinoma; targeted therapies; drug delivery systems; nanoparticles; controlled drug delivery; circadian clock; chronotherapy; precision medicine 2020-05-19T14:47:16Z 2020-05-19T14:47:16Z 2019-06-30 2019-06 2020-03-02T12:53:48Z Article http://purl.org/eprint/type/JournalArticle 1999-4923 https://hdl.handle.net/1721.1/125310 Ketabat, Farinaz, et al., "Controlled drug delivery systems for oral cancer treatment--current status and future perspectives." Pharmaceutics 11, 7 (June 2019): no. 302 doi 10.3390/pharmaceutics11070302 ©2019 Author(s) 10.3390/pharmaceutics11070302 Pharmaceutics Creative Commons Attribution https://creativecommons.org/licenses/by/4.0/ application/pdf Multidisciplinary Digital Publishing Institute Multidisciplinary Digital Publishing Institute |
| spellingShingle | Koutsopoulos, Sotirios Controlled drug delivery systems for oral cancer treatment--current status and future perspectives |
| title | Controlled drug delivery systems for oral cancer treatment--current status and future perspectives |
| title_full | Controlled drug delivery systems for oral cancer treatment--current status and future perspectives |
| title_fullStr | Controlled drug delivery systems for oral cancer treatment--current status and future perspectives |
| title_full_unstemmed | Controlled drug delivery systems for oral cancer treatment--current status and future perspectives |
| title_short | Controlled drug delivery systems for oral cancer treatment--current status and future perspectives |
| title_sort | controlled drug delivery systems for oral cancer treatment current status and future perspectives |
| url | https://hdl.handle.net/1721.1/125310 |
| work_keys_str_mv | AT koutsopoulossotirios controlleddrugdeliverysystemsfororalcancertreatmentcurrentstatusandfutureperspectives |